- Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60)2013 | Lékařská fakulta v Hradci Králové
- Distinct cellular responses to replication stress leading to apoptosis or senescence2019 | Lékařská fakulta v Hradci Králové
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Lékařská fakulta v Hradci Králové
- Novel caffeine derivatives with antiproliferative activity2016 | Lékařská fakulta v Hradci Králové
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Lékařská fakulta v Hradci Králové
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publikace bez příslušnosti k fakultě
- DNA repair inhibitors as radiosensitizers in human lung cells2018 | Publikace bez příslušnosti k fakultě
- Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis2014 | Lékařská fakulta v Hradci Králové
- Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells2016 | Lékařská fakulta v Hradci Králové